Evidence Roadmap

Clear evidence labels for a therapist-led AI platform.

We separate current guideline-grounded clinical decision support from workflow-impact evidence we are collecting and outcomes we do not claim.

Current evidence base for Citt Evidence

Citt Evidence is clinical decision support for therapists. It is grounded in curated guideline summaries and therapist resources, not positioned as a standalone clinical authority.

NICE

Chronic pain in over 16s (NG193)

APA

Cognitive behavioural therapy evidence base

NICE

Anxiety disorders guidance

WHO

mhGAP intervention guide

Cochrane

Psychological therapies for chronic pain

NICE

ADHD in adults

APA

Post-traumatic stress disorder guideline

APA

Major depressive disorder guideline

NICE

Bipolar disorder assessment and management

APA

Bipolar disorder practice guideline

NICE

Eating disorders guidance

NICE

Obsessive-compulsive disorder guidance

NICE

Borderline personality disorder guidance

NICE

Insomnia and sleep problems guidance

NICE

Substance use and co-occurring mental health guidance

APA

Social anxiety disorder guidance

NICE

Post-traumatic stress disorder (NG116)

Cochrane

Depression psychotherapy reviews

Workflow-impact evidence we are collecting

These are roadmap measurement areas. They are not marketed as proven product impact until measured and reviewed.

Patient engagement with check-ins and between-session support
No-show and attendance patterns
Clinical note turnaround time
Therapist review workload and response patterns
Patient consent and device delivery preferences

Evidence we are not claiming yet

These claims require evidence that Citt.ai is not currently presenting as measured product proof.

Clinical efficacy for treating a condition
Equivalence to therapy delivered by a licensed clinician
A guarantee that risk screening catches every crisis
A measured capacity multiplier for how many patients a therapist can support
Autonomous diagnosis, treatment, or medication advice